Who Has to Comply?
The Regulatory Landscape
QMSR: The Current U.S. Framework
ISO 13485: 2016, Clause 7.3
EU MDR 2017/745
The Design Control Process
The 9 Elements of Design Controls
1. Design and Development Planning
2. Design Input
3. Design Output
4. Design Review
5. Design Verification
6. Design Validation
7. Design Transfer
8. Design Changes
9. Design History File (DHF)
Common FDA 483 Findings for Design Controls
How QMS Software Supports Design Controls
Leading QMS Platforms
Greenlight Guru
Best for small companies with 10-50 employees and mid-sized businesses with 50-1,000 employees in the medical device industry. Not for companies outside of the medical device industry, or startups with fewer than 10 employees.
What we like
- Responsive customer support
- Intuitive, user-friendly interface
- Automated document routing and revision control
What we don’t like
- Tedious mass document input
- Detailed, specialized modules can pose a learning curve
Starting at $12,000/yearWeb clientCloud hosted
Qualio
Best for organizations in the life sciences sector that need ISO and FDA compliance. Industries include medical devices, software as a medical device (SaMD), pharmaceuticals, cannabis, biotech and contract research organizations.
What we like
- Meets FDA standards
- Good fit for first-time QMS
- Reduces physical paper trail
What we don’t like
- Potentially complex setup
- Limited non-life science use
- Requires regular updates for best performance
Starting at $12,000/yearWeb clientCloud hostedPlatform price, then $3000 per user model
MasterControl
Best for medium to large enterprises in regulated industries like pharmaceuticals, medical devices, and biotechnology, where compliance with quality standards is critical. It is especially beneficial for organizations looking to digitize their quality processes and integrate various aspects of their QMS.
What we like
- Completes validation quickly
- Includes automated notification system
- Seamless integration between modules
What we don’t like
- High learning curve
- Requires consult call for pricing
- User interface can be slow at times
Web clientCloud hosted
QT9 QMS
What we like
- Flexible deployment options with access on all devices.
- Has 25+ pre-installed modules for advanced functionality.
- Full validation included for life sciences companies.
What we don’t like
- Implementation and training are required plus an additional fee.
- No pre-built QuickBooks integration.
Starting at $2,200/user/yearWindows, macOS, Linux, iOS, Android, Web clientsCloud hosted or on premisesConcurrent licensing for users.
uniPoint QMS
What we like
- Configurable, modular design with a variety of add-on modules
- Mobile-first design on uniPoint Web version
- Allows concurrent users rather than named seats
What we don’t like
- No set pricing due to configurable design
- Certain industries may require add-ons to meet compliance or certification
- Not a fit for businesses looking for a LMS system
Starting at $225/user/monthWindows, Web clientsCloud hosted or on premises
Frequently Asked Questions
Design controls should begin when research ends, and formal design and development begin, specifically when you’re designing the final product intended for commercialization. Early feasibility work and proof-of-concept prototyping typically fall outside design controls, but once you’re designing something you intend to manufacture and sell, controls must be in place. The design and development procedure should be one of the first SOPs implemented in your quality system.
Yes. The FDA does not mandate a waterfall approach. The 1997 Design Control Guidance explicitly acknowledges iterative development. Many companies, particularly those developing software-driven devices, use agile or hybrid methodologies. The key is ensuring that every iteration is documented, that design inputs and outputs are captured and traced regardless of sprint structure, and that verification, validation, and design reviews still happen at appropriate points. Agile within design controls requires discipline around documentation, but it’s entirely compatible with the regulation.
An FDA inspector who identifies design control deficiencies will issue a Form 483 observation. If the issues are serious or systemic, the FDA may issue a warning letter, which becomes public and can delay or block 510(k) clearances. In severe cases, the FDA can pursue consent decrees, import bans, or injunctions. For ISO 13485 audits, nonconformities can result in loss of certification, which blocks access to EU and other international markets. The most practical consequence of failing a design controls audit is significant time and cost spent on remediation when the same effort invested upfront would have prevented the finding entirely.
